Effects of thioacetamide on pancreatic islet B-cell function
Thioacetamide (0.01-1.3 mM) fails to exert any significant immediate effect upon insulin release from rat isolated islets. However, when administered (4 micromol/g body wt) intraperitoneally 24 h before sacrifice, it reduced food intake and body weight and affected the secretory response of isolated...
Gespeichert in:
Veröffentlicht in: | Endocrine 2004-06, Vol.24 (1), p.83-92 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 92 |
---|---|
container_issue | 1 |
container_start_page | 83 |
container_title | Endocrine |
container_volume | 24 |
creator | Malaisse, Willy J Lebrun, Philippe Sener, Abdullah Wolters, Gerrit H J Ravazzola, Mariella |
description | Thioacetamide (0.01-1.3 mM) fails to exert any significant immediate effect upon insulin release from rat isolated islets. However, when administered (4 micromol/g body wt) intraperitoneally 24 h before sacrifice, it reduced food intake and body weight and affected the secretory response of isolated islets to several secretagogues, despite unaltered insulin content of such islets. This coincided with a decrease in D-[U-14C]glucose oxidation, total islet calcium content and the ionized calcium content of secretory granules in islet B-cells, and changes in both 133Ba and 45Ca net uptake. Likewise, in islets prepared from thioacetamide-injected rats and prelabeled with 45Ca before perifusion, the cationic and insulin secretory responses to D-glucose or gliclazide, but not to the association of Ba2+ and theophylline in the absence of extracellular Ca2+, often differed from that otherwise found in islets prepared from control rats. These findings are interpreted as indicative of an impaired capacity of Ca2+ sequestration by intracellular organelles in the islet B-cells of thioacetamide-treated rats. |
doi_str_mv | 10.1385/ENDO:24:1:083 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66699794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66699794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c291t-2f21677a04f239a1d62f40183562d8a5d38adadbf57080523cb8562ba18d9463</originalsourceid><addsrcrecordid>eNpFkLlOAzEARC0EIiFQ0iJXdAYf6yuiISEcUkSaFOksrw-xaI-w9hb8PRslEtUU8zQaPQBuCX4gTPHH1efLZk6LOZljxc7AFGuhkSRkdw6mhHGOMFa7CbhK6RtjSqmQl2BCOC20xHIKnlYxBpcT7CLMX1VnXci2qXyAXQv3tnV9sLlysEp1yHCBXKhrGIfW5aprr8FFtHUKN6ecge3rart8R-vN28fyeY0c1SQjGikRUlpcRMq0JV7QWGCiGBfUK8s9U9ZbX0YuscKcMleqsSotUV4Xgs3A_XF233c_Q0jZNFU6HLFt6IZkhBBaS12MIDqCru9S6kM0-75qbP9rCDYHW-Zgy9DCEDPaGvm70_BQNsH_0yc97A-DWmQx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66699794</pqid></control><display><type>article</type><title>Effects of thioacetamide on pancreatic islet B-cell function</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Malaisse, Willy J ; Lebrun, Philippe ; Sener, Abdullah ; Wolters, Gerrit H J ; Ravazzola, Mariella</creator><creatorcontrib>Malaisse, Willy J ; Lebrun, Philippe ; Sener, Abdullah ; Wolters, Gerrit H J ; Ravazzola, Mariella</creatorcontrib><description>Thioacetamide (0.01-1.3 mM) fails to exert any significant immediate effect upon insulin release from rat isolated islets. However, when administered (4 micromol/g body wt) intraperitoneally 24 h before sacrifice, it reduced food intake and body weight and affected the secretory response of isolated islets to several secretagogues, despite unaltered insulin content of such islets. This coincided with a decrease in D-[U-14C]glucose oxidation, total islet calcium content and the ionized calcium content of secretory granules in islet B-cells, and changes in both 133Ba and 45Ca net uptake. Likewise, in islets prepared from thioacetamide-injected rats and prelabeled with 45Ca before perifusion, the cationic and insulin secretory responses to D-glucose or gliclazide, but not to the association of Ba2+ and theophylline in the absence of extracellular Ca2+, often differed from that otherwise found in islets prepared from control rats. These findings are interpreted as indicative of an impaired capacity of Ca2+ sequestration by intracellular organelles in the islet B-cells of thioacetamide-treated rats.</description><identifier>ISSN: 1355-008X</identifier><identifier>ISSN: 0969-711X</identifier><identifier>EISSN: 0969-711X</identifier><identifier>DOI: 10.1385/ENDO:24:1:083</identifier><identifier>PMID: 15249707</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Body Weight - drug effects ; Calcium - metabolism ; Eating - drug effects ; Female ; Glucose - metabolism ; Injections, Intraperitoneal ; Insulin - blood ; Insulin - metabolism ; Insulin Secretion ; Islets of Langerhans - drug effects ; Islets of Langerhans - metabolism ; Microscopy, Immunoelectron ; Perfusion ; Radioisotopes ; Rats ; Thioacetamide - pharmacology</subject><ispartof>Endocrine, 2004-06, Vol.24 (1), p.83-92</ispartof><rights>Copyright 2004 Humana Press Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c291t-2f21677a04f239a1d62f40183562d8a5d38adadbf57080523cb8562ba18d9463</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15249707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malaisse, Willy J</creatorcontrib><creatorcontrib>Lebrun, Philippe</creatorcontrib><creatorcontrib>Sener, Abdullah</creatorcontrib><creatorcontrib>Wolters, Gerrit H J</creatorcontrib><creatorcontrib>Ravazzola, Mariella</creatorcontrib><title>Effects of thioacetamide on pancreatic islet B-cell function</title><title>Endocrine</title><addtitle>Endocrine</addtitle><description>Thioacetamide (0.01-1.3 mM) fails to exert any significant immediate effect upon insulin release from rat isolated islets. However, when administered (4 micromol/g body wt) intraperitoneally 24 h before sacrifice, it reduced food intake and body weight and affected the secretory response of isolated islets to several secretagogues, despite unaltered insulin content of such islets. This coincided with a decrease in D-[U-14C]glucose oxidation, total islet calcium content and the ionized calcium content of secretory granules in islet B-cells, and changes in both 133Ba and 45Ca net uptake. Likewise, in islets prepared from thioacetamide-injected rats and prelabeled with 45Ca before perifusion, the cationic and insulin secretory responses to D-glucose or gliclazide, but not to the association of Ba2+ and theophylline in the absence of extracellular Ca2+, often differed from that otherwise found in islets prepared from control rats. These findings are interpreted as indicative of an impaired capacity of Ca2+ sequestration by intracellular organelles in the islet B-cells of thioacetamide-treated rats.</description><subject>Animals</subject><subject>Body Weight - drug effects</subject><subject>Calcium - metabolism</subject><subject>Eating - drug effects</subject><subject>Female</subject><subject>Glucose - metabolism</subject><subject>Injections, Intraperitoneal</subject><subject>Insulin - blood</subject><subject>Insulin - metabolism</subject><subject>Insulin Secretion</subject><subject>Islets of Langerhans - drug effects</subject><subject>Islets of Langerhans - metabolism</subject><subject>Microscopy, Immunoelectron</subject><subject>Perfusion</subject><subject>Radioisotopes</subject><subject>Rats</subject><subject>Thioacetamide - pharmacology</subject><issn>1355-008X</issn><issn>0969-711X</issn><issn>0969-711X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkLlOAzEARC0EIiFQ0iJXdAYf6yuiISEcUkSaFOksrw-xaI-w9hb8PRslEtUU8zQaPQBuCX4gTPHH1efLZk6LOZljxc7AFGuhkSRkdw6mhHGOMFa7CbhK6RtjSqmQl2BCOC20xHIKnlYxBpcT7CLMX1VnXci2qXyAXQv3tnV9sLlysEp1yHCBXKhrGIfW5aprr8FFtHUKN6ecge3rart8R-vN28fyeY0c1SQjGikRUlpcRMq0JV7QWGCiGBfUK8s9U9ZbX0YuscKcMleqsSotUV4Xgs3A_XF233c_Q0jZNFU6HLFt6IZkhBBaS12MIDqCru9S6kM0-75qbP9rCDYHW-Zgy9DCEDPaGvm70_BQNsH_0yc97A-DWmQx</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>Malaisse, Willy J</creator><creator>Lebrun, Philippe</creator><creator>Sener, Abdullah</creator><creator>Wolters, Gerrit H J</creator><creator>Ravazzola, Mariella</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040601</creationdate><title>Effects of thioacetamide on pancreatic islet B-cell function</title><author>Malaisse, Willy J ; Lebrun, Philippe ; Sener, Abdullah ; Wolters, Gerrit H J ; Ravazzola, Mariella</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c291t-2f21677a04f239a1d62f40183562d8a5d38adadbf57080523cb8562ba18d9463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Body Weight - drug effects</topic><topic>Calcium - metabolism</topic><topic>Eating - drug effects</topic><topic>Female</topic><topic>Glucose - metabolism</topic><topic>Injections, Intraperitoneal</topic><topic>Insulin - blood</topic><topic>Insulin - metabolism</topic><topic>Insulin Secretion</topic><topic>Islets of Langerhans - drug effects</topic><topic>Islets of Langerhans - metabolism</topic><topic>Microscopy, Immunoelectron</topic><topic>Perfusion</topic><topic>Radioisotopes</topic><topic>Rats</topic><topic>Thioacetamide - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malaisse, Willy J</creatorcontrib><creatorcontrib>Lebrun, Philippe</creatorcontrib><creatorcontrib>Sener, Abdullah</creatorcontrib><creatorcontrib>Wolters, Gerrit H J</creatorcontrib><creatorcontrib>Ravazzola, Mariella</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malaisse, Willy J</au><au>Lebrun, Philippe</au><au>Sener, Abdullah</au><au>Wolters, Gerrit H J</au><au>Ravazzola, Mariella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of thioacetamide on pancreatic islet B-cell function</atitle><jtitle>Endocrine</jtitle><addtitle>Endocrine</addtitle><date>2004-06-01</date><risdate>2004</risdate><volume>24</volume><issue>1</issue><spage>83</spage><epage>92</epage><pages>83-92</pages><issn>1355-008X</issn><issn>0969-711X</issn><eissn>0969-711X</eissn><abstract>Thioacetamide (0.01-1.3 mM) fails to exert any significant immediate effect upon insulin release from rat isolated islets. However, when administered (4 micromol/g body wt) intraperitoneally 24 h before sacrifice, it reduced food intake and body weight and affected the secretory response of isolated islets to several secretagogues, despite unaltered insulin content of such islets. This coincided with a decrease in D-[U-14C]glucose oxidation, total islet calcium content and the ionized calcium content of secretory granules in islet B-cells, and changes in both 133Ba and 45Ca net uptake. Likewise, in islets prepared from thioacetamide-injected rats and prelabeled with 45Ca before perifusion, the cationic and insulin secretory responses to D-glucose or gliclazide, but not to the association of Ba2+ and theophylline in the absence of extracellular Ca2+, often differed from that otherwise found in islets prepared from control rats. These findings are interpreted as indicative of an impaired capacity of Ca2+ sequestration by intracellular organelles in the islet B-cells of thioacetamide-treated rats.</abstract><cop>United States</cop><pmid>15249707</pmid><doi>10.1385/ENDO:24:1:083</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-008X |
ispartof | Endocrine, 2004-06, Vol.24 (1), p.83-92 |
issn | 1355-008X 0969-711X 0969-711X |
language | eng |
recordid | cdi_proquest_miscellaneous_66699794 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Body Weight - drug effects Calcium - metabolism Eating - drug effects Female Glucose - metabolism Injections, Intraperitoneal Insulin - blood Insulin - metabolism Insulin Secretion Islets of Langerhans - drug effects Islets of Langerhans - metabolism Microscopy, Immunoelectron Perfusion Radioisotopes Rats Thioacetamide - pharmacology |
title | Effects of thioacetamide on pancreatic islet B-cell function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T14%3A05%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20thioacetamide%20on%20pancreatic%20islet%20B-cell%20function&rft.jtitle=Endocrine&rft.au=Malaisse,%20Willy%20J&rft.date=2004-06-01&rft.volume=24&rft.issue=1&rft.spage=83&rft.epage=92&rft.pages=83-92&rft.issn=1355-008X&rft.eissn=0969-711X&rft_id=info:doi/10.1385/ENDO:24:1:083&rft_dat=%3Cproquest_cross%3E66699794%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66699794&rft_id=info:pmid/15249707&rfr_iscdi=true |